Westmoreland Pharmacy and Compounding hosts a NAD+ provider order form that lists injectable, nasal, and topical preparations with prices. The form is stored in a 2025 document path and remained publicly accessible when we checked it. Its detail is useful, but the older document should not be presented as a guaranteed current checkout offer.
We reviewed the form on September 19, 2026 without submitting it or contacting the pharmacy as a patient. This is a supplier-document review, not a report of receiving treatment. It distinguishes the information on the form from the current price, availability, and instructions that require pharmacy confirmation.
Use Westmoreland’s 2025 form as documented background, not a guaranteed current price. Confirm the prescription, supply period, shipping, and dispensing terms with the pharmacy.
What the form tells a reader
The public order form lists a 200 mg/mL injectable preparation in multi-dose vials alongside nasal spray and cream. It provides fields for patient information, allergies, the prescriber, and a signature. That structure shows a prescription workflow rather than an unrestricted retail supplement purchase.
The supplied amount and directions still need to come from the clinician and pharmacy. Our label-reading guide explains why a catalog concentration should not be turned into a self-selected regimen. We do not reproduce the form’s example dosing table as instructions for readers.
Treat the printed prices as dated examples
The form lists injection quantities with prices ranging from $95 to $220 and includes a shipping-fee entry. These figures document what the hosted form says; they do not establish today’s stock, final shipping charge, or the amount a particular prescription would cost. Ask the pharmacy for a current written quote.
Also separate the medication charge from the cost of seeing a clinician. The NAD+ cost guide explains why a pharmacy order form and a bundled telehealth plan are different offers. A lower-looking supplier price may omit evaluation, prescribing, supplies, or ongoing care that another service includes.
The supply-limit statement matters
The form says its injectable preparation is not dispensed as more than a one-month supply and links that limit to sterility considerations. Treat that as the pharmacy’s statement about the offering, not a universal rule establishing the usable period of every NAD+ product from every pharmacy.
Ask how the current prescription quantity, dispensing date, and labeled usable dates fit together. If a clinic proposes a longer paid program, clarify whether medication is shipped in stages. A long purchase commitment and the time a particular vial can be used are separate questions that should be answered explicitly.
Shipping and pickup are different arrangements
Westmoreland’s form provides options for patient pickup, shipment to the patient, and shipment to a clinic. Ask which is available for your location and prescription and who takes responsibility for handling questions after delivery. A printed shipping option does not establish that the pharmacy can send every preparation to every state.
For a clinic shipment, identify who will administer the product and how follow-up is arranged. For a home shipment, ask who explains the supplies and label. The pharmacy-checking guide helps organize the facility and dispensing questions without assuming that the order form supplies the whole care plan.
Keep the three formulations separate
The cream, spray, and injection entries are different preparations, with different packaging and instructions. Their prices should not be ranked as if they buy the same intervention. Ask the clinician why the proposed route fits the intended goal and what evidence supports the actual preparation.
The route comparison guide and evidence overview explain those distinctions. A pharmacy’s willingness to compound a product does not establish that it reliably improves energy, cognition, or aging-related outcomes. The medical decision should be separate from selecting an item on a form.
Compare current quotes, not older price tables
Read Lavender Sky Health for an example of a prescribing service with a pharmacy-specific menu and Belmar Pharma Solutions for another supplier covering several routes. MediVera provides a useful comparison for preparation and usable-date questions.
Our CoreAge Rx review covers the featured commercial partner and does not imply a Westmoreland supply relationship. Westmoreland’s public form adds meaningful detail to the supplier directory, provided its date and limits remain visible. A current quote and prescription-specific guidance should replace the older figures before a purchase decision is made.
Follow the source
References & further reading
- Westmoreland — NAD+ provider order form
Checked September 19, 2026. Publicly hosted 2025 form with dated price examples and pharmacy-specific supply wording; current quote required.
- FDA — compounding questions and answers
Compounded drugs are not FDA-approved or reviewed before marketing for safety, effectiveness, or quality.
- FDA — ingredients suitable for sterile compounding
Reports NAD+ injectable adverse events and ingredient-quality concerns.
- Grant et al. (2019) — human NAD+ infusion pilot
Small IV metabolism study; does not establish benefits of home injections.